Synthesis and evaluation of a new series of 3,5-bis((5-bromo-6-methyl-2-t-aminopyrimidin-4-yl)thio)-4H-1,2,4-triazol-4-amines and their cyclized products 'pyrimidinylthio pyrimidotriazolothiadiazines' as 15- lipo-oxygenase inhibitors

New Multifunctional Bipyrimidine-Based Chromophores for NLO-Active Thin-Film Preparation

New synthesized bipyrimidine-based chromophores presenting alkoxystyryl donor groups carrying aliphatic achiral and chiral chains in the 4 position, connected to electron-accepting 2,2-bipyrimidine cores have been synthesized. Their linear and nonlinear optical (NLO) properties were investigated as well as their mesomorphic properties by various techniques (light-transmission measurements, polarized-light optical microscopy, differential scanning calorimetry measurements and two-photon excited fluorescence). The derivatives with achiral linear carbon chains were found to exhibit liquid-crystal properties with the formation smectic phases over large temperature ranges, which were confirmed by small-angle X-ray scattering analysis via stacking models. The nonlinear optical properties in the solid state for derivatives with C14 and the citronellol chains have been studied by wide-field second-harmonic generation and multi-photon fluorescence imaging, confirming centrosymmetry for these achiral mesogens and their excellent third-order nonlinearity whereas the chiral compound exhibits non-centrosymmetric organization resulting in a strong Second Harmonic Generation at the crystal state.

Synthesis of new derivatives of 4-(4-methyl-5H-pyrimido[4,5-b][1,4]thiazin-2-yl)morpholine and 4-methyl-2-(piperidin-1-yl)-5H-pyrimido[4,5-b][1,4]thiazine

Several derivatives of the novel 4-(4-methyl-5 H-pyrimido[4,5- b][1,4]thiazin-2-yl)morpholine and 4-methyl-2-(piperidin-1-yl)-5 H-pyrimido[4,5- b][1,4]thiazine ring systems have been synthesised through cyclocondensation of 5-amino-6-methylpyrimidine-4-thiols and the appropriate α-haloketone in glacial acetic acid under reflux.

Synthesis and characterisation of new 3-methyl-6-[1-(pyrimidin-4-yl)ethyl]-5H-pyrimido[5,4-e][1,2,4]triazolo[3,4-b][1,3,4]thiadiazine derivatives

A new series of 3-methyl-6-[1-(pyrimidin-4-yl)ethyl]-5 H-pyrimido[5,4- e][1,2,4]triazolo[3,4- b][1,3,4]thiadiazine derivatives was synthesised through the condensation reaction of 5-bromo-4-[1-(5-bromo-2,6-dichloropyrimidin-4-yl)ethyl]-2-chloro-6-methylpyrimidine and 4-amino-5-methyl-4 H-1,2,4-triazole-3-thiol.

Synthesis and Density Functional Theory Study of [1,2,3]Triazolo[4,5-d][1,2,4] Triazolo[4,3-a]Pyrimidine Derivatives: A Novel Heterocyclic System

Several 3H-[1,2,3]triazolo[4,5-d][1,2,4]triazolo[4,3-a]pyrimidine derivatives of a novel ring system have been synthesised. The initial substitution of the 4-Cl function of 2,4-dichloro-6-methylpyrimidin-5-amine with benzylamine followed by treatment with sodium nitrite generated 3-benzyl-5-chloro-7-methyl-3H-[1,2,3]triazolo[4,5-d]pyrimidine. Nucleophilic substitution of the 5-Cl moiety of the latter compound with hydrazine hydrate and subsequent treatment with carbon disulfide in boiling pyridine gave, quantitatively, the corresponding [1,2,3]triazolo[4,5-d][1,2,4]triazolo[4,3-a]pyrimidine derivatives. Density functional theory (DFT) studies were also performed to reveal regioselectivity of the ring closure via Gauge-Independent Atomic Orbital (GIAO) 1H NMR calculations. The WP04 method was used as the DFT code to yield accurate chemical shift values. Theoretical results correlated well with the expected regioisomer and aided assignment of the final structure.

Activity-Based Probes for 15-Lipoxygenase-1

Human 15-lipoxygenase-1 (15-LOX-1) plays an important role in several inflammatory lung diseases, such as asthma, COPD, and chronic bronchitis, as well as various CNS diseases, such as Alzheimer's disease, Parkinson's disease, and stroke. Activity-based probes of 15-LOX-1 are required to explore the role of this enzyme further and to enable drug discovery. In this study, we developed a 15-LOX-1 activity-based probe for the efficient activity-based labeling of recombinant 15-LOX-1. 15-LOX-1-dependent labeling in cell lysates and tissue samples was also possible. To mimic the natural substrate of the enzyme, we designed activity-based probes that covalently bind to the active enzyme and include a terminal alkene as a chemical reporter for the bioorthogonal linkage of a detectable functionality through an oxidative Heck reaction. The activity-based labeling of 15-LOX-1 should enable the investigation and identification of this enzyme in complex biological samples, thus opening up completely new opportunities for drug discovery.

Synthesis of New Derivatives of Pyridazino[6,1-c]Pyrimido[5,4-e][1,2,4]Triazine; a Novel Heterocyclic System

Several derivatives of the novel pyridazino[6,1-c]pyrimido[5,4-e][1,2,4]triazine ring system have been synthesised through heterocyclisation of 5-bromo-2,4-dichloro-6-methylpyrimidine with 3-chloro-6-hydrazinylpyridazine followed by treatment with secondary amines in boiling ethanol.

Rational Development of a Potent 15-Lipoxygenase-1 Inhibitor with in Vitro and ex Vivo Anti-inflammatory Properties

Human 15-lipoxygenase-1 (h-15-LOX-1) is a mammalian lipoxygenase and plays an important role in several inflammatory lung diseases such as asthma, COPD, and chronic bronchitis. Novel potent inhibitors of h-15-LOX-1 are required to explore the role of this enzyme further and to enable drug discovery efforts. In this study, we applied an approach in which we screened a fragment collection that is focused on a diverse substitution pattern of nitrogen-containing heterocycles such as indoles, quinolones, pyrazoles, and others. We denoted this approach substitution-oriented fragment screening (SOS) because it focuses on the identification of novel substitution patterns rather than on novel scaffolds. This approach enabled the identification of hits with good potency and clear structure-activity relationships (SAR) for h-1-5-LOX-1 inhibition. Molecular modeling enabled the rationalization of the observed SAR and supported structure-based design for further optimization to obtain inhibitor 14 d that binds with a Ki of 36 nM to the enzyme. In vitro and ex vivo biological evaluations of our best inhibitor demonstrate a significant increase of interleukin-10 (IL-10) gene expression, which indicates its anti-inflammatory properties.